Carolinas Wealth Consulting LLC Gilead Sciences, Inc. Transaction History

Carolinas Wealth Consulting LLC

$542 Million
Q2 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 444 shares of GILD stock, worth $37,216. This represents 0.01% of its overall portfolio holdings.

Number of Shares

444

Previous 444 -0.0%

Holding current value

$37,216

Previous $32,000 6.25%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $25,768 - $31,424	360 Added 428.57%	444 $32,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $2,491 - $2,825	-34 Reduced 28.81%	84 $6,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $104,477 - $113,986	-1,413 Reduced 92.29%	118 $8,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $304 - $346	4 Added 0.26%	1,531 $117,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1,005 - $1,145	-13 Reduced 0.84%	1,527 $126,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $249 - $357	-4 Reduced 0.26%	1,540 $132,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1,012 - $1,156	17 Added 1.11%	1,544 $95,000
Q2 2022 Aug 16, 2022	BUY	$57.72 - $65.01 $21,356 - $24,053	370 Added 31.98%	1,527 $94,000
Q1 2022 May 17, 2022	SELL	$57.92 - $72.58 $1,100 - $1,379	-19 Reduced 1.62%	1,157 $69,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $3,179 - $3,608	-49 Reduced 4.0%	1,176 $85,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $35,469 - $38,267	-524 Reduced 29.96%	1,225 $86,000
Q2 2021 Aug 17, 2021	SELL	$63.47 - $69.35 $45,444 - $49,654	-716 Reduced 29.05%	1,749 $120,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $660 - $753	11 Added 0.45%	2,465 $159,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $168,193 - $191,648	-2,969 Reduced 54.75%	2,454 $143,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $62,472 - $78,548	1,006 Added 22.78%	5,423 $343,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $2,821 - $3,276	39 Added 0.89%	4,417 $340,000
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $17,912 - $22,942	-286 Reduced 6.13%	4,378 $328,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $287,395 - $316,125	4,664 New	4,664 $301,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Account

Carolinas Wealth Consulting LLC Gilead Sciences, Inc. Transaction History